<PAGE> 1
Page 1 of 4
OMB APPROVAL
-------------------------
OMB Number: 3235-0287
-------------------------
Expires: October 31, 2001
-------------------------
Estimated average burden
hours per response...0.5
-------------------------
FORM 4/A
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[_] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
(Print or Type Responses)
________________________________________________________________________________
1. Name and Address of Reporting Person*
Commonwealth Associates, LP
--------------------------------------------------------------------------------
(Last) (First) (Middle)
830 Third Avenue
--------------------------------------------------------------------------------
(Street)
New York New York 10022
--------------------------------------------------------------------------------
(City) (State) (Zip)
______________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
ProxyMed, Inc. (NASDAQ National Market:PILL)
--------------------------------------------------------------------------------
________________________________________________________________________________
3. IRS or Social Security Number of Reporting Person, if an entity (Voluntary)
13-3467952
________________________________________________________________________________
4. Statement for Month/Year
November 2000
---------------------------------------------------------------------------
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
December 2000
================================================================================
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[X] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
Michael S. Falk is a director
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check Applicable Line)
[_] Form filed by One Reporting Person
[X] Form filed by More than One Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (Month/Day/Year) Code V (D) and 4) (Instr.4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock 11/20/00 P 5,000 A $0.96875 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/21/00 P 5,000 A $1.00 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/21/00 P 5,000 A $1.01 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/21/00 P 30,000 A $0.985 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/21/00 P 10,000 A $0.96875 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/22/00 P 20,000 A $1.01 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 11/22/00 P 25,000 A $0.98 122,666 D(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 62,500 I (2)
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
<PAGE> 2
FORM 4 (continued) Page 2 of 4
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
Explanation of Responses:
See Attached
</TABLE>
Commonwealth Associates L.P.
By: Commonwealth Associates Management Corp., its general partner
/s/ Joseph P. Wynne December 8, 2000
--------------------------------------------- -----------------------
**Signature of Reporting Person Date
Joseph P. Wynne, Chief Financial Officer
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a current
valid OBM Number.
2 of 2
<PAGE> 3
Page 3 of 4
FOOTNOTES
---------
(1) These shares were acquired, and are owned directly by, Commonwealth
Associates, L.P. ("Commonwealth") . Michael S. Falk ("Falk") is the principal
limited partner of Commonwealth, and is a director, the Chairman and the
principal shareholder of Commonwealth Associates Management Corp., the general
partner of Commonwealth. Falk disclaims beneficial ownership of the securities
held by Commonwealth other than that portion which corresponds with his equity
ownership in Commonwealth.
(2) These shares are owned directly by Falk.
<PAGE> 4
Page 4 of 4
JOINT FILER INFORMATION AND AUTHORIZATION
-----------------------------------------
Name: Commonwealth Associates Management Corp.
830 Third Avenue
New York, New York 10022
Designated Filer: Commonwealth Associates, LP
Issuer & Ticker Symbol: ProxyMed, Inc. (PILL)
Statement Month/Year: November 2000
Signature: By: /s/ Joseph Wynne
-------------------------------------------
Joseph Wynne, Chief Financial Officer
Name: Michael S. Falk
830 Third Avenue
New York, New York 10022
Designated Filer: Commonwealth Associates, LP
Issuer & Ticker Symbol: ProxyMed, Inc. (PILL)
Statement Month/Year: November 2000
Signature: /s/ Michael S. Falk
-----------------------
Michael S. Falk
